CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer - Marmé, Frederik; Werft, Wiebke; Keller, Sascha; Wang, Xiaoli; Benner, Axel; Burwinkel, Barbara; Sinn, Peter; Fastner, Sarah; Sohn, Christof; Moldenhauer, Gerhard; Rupp, Christian; Rupp, Anne-Kathleen; et al. (Breast cancer research and treatment, 2012)
Published online 30 September 2011